CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | FELDBAUM CARL B Director | Exercise or conversion · Option (right to buy) | −20,000 | 0 | ||
| 2021-02-15 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −1,400 | $21.91 | $31K | 245,487 |
| 2021-02-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −4,105 | $21.91 | $90K | 292,441 |
| 2021-02-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −1,685 | $21.91 | $37K | 589,113 |
| 2021-02-15 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −2,858 | $21.91 | $63K | 540,597 |
| 2021-02-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −9,789 | $21.91 | $214K | 559,187 |
| 2021-02-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −3,718 | $21.91 | $81K | 340,072 |
| 2021-02-12 | Haley Patrick J. EVP, Commercial | Sale | −45,000 | $21.57 | $971K | 246,887 |
| 2021-02-03 | MORRISSEY MICHAEL President and CEO | Grant or award | +23,238 | 409,879 | ||
| 2021-02-03 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −65,190 | $22.56 | $1.5M | 568,976 |
| 2021-02-03 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +9,370 | 292,494 | ||
| 2021-02-03 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +71,293 | 363,787 | ||
| 2021-02-03 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −19,997 | $22.56 | $451K | 343,790 |
| 2021-02-03 | Hessekiel Jeffrey EVP and General Counsel | Grant or award | +4,998 | 546,752 | ||
| 2021-02-03 | Hessekiel Jeffrey EVP and General Counsel | Grant or award | +59,411 | 606,163 | ||
| 2021-02-03 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −15,365 | $22.56 | $347K | 590,798 |
| 2021-02-03 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Grant or award | +9,745 | 487,144 | ||
| 2021-02-03 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Grant or award | +71,293 | 558,437 | ||
| 2021-02-03 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −14,982 | $22.56 | $338K | 543,455 |
| 2021-02-03 | Haley Patrick J. EVP, Commercial | Grant or award | +4,498 | 243,743 |
Page 36 of 42 · 836 trades